Table 3 Chemotherapy regimen given in first and second line setting
From: Metastatic colo-rectal cancer: real life experience from an Indian tertiary care center
Chemotherapy Line | Regimen | N (%) |
|---|---|---|
First line | CapeOx | 166 (44%) |
FOLFOX | 75 (20%) | |
FOLFIRI | 49 (13%) | |
CAPIRI | 34 (9%) | |
Capecitabine | 11 (3%) | |
FOLFOXIRI | 5 (1.3%) | |
Others (FUFA, FLOX, IFL) | 37 (10%) | |
Second line N = 124 | FOLFIRI | 47 (37%) |
CAPIRI | 27 (22%) | |
FOLFOX | 19 (15%) | |
CapeOx | 14 (11.3%) | |
Others (IFL, Capecitabine, UFT, FOLFOXIRI, Irinotecan) | 17 (14%) |